Different studies using RNA microarrays detected high levels of VRK1 expression in estrogen receptor positive breast cancer and at the same time the group with high VRK1 identified patients with a poorer prognosis [3, 4, 6, 27]. This evidence concerns the gene VRK1 and breast carcinoma.